Pakistan ranks fifth globally in the number of tuberculosis (TB) cases and fourth for drug-resistant TB, a concerning ...

An experimental drug now in clinical trials as a cancer treatment could help boost the power of first-line tuberculosis (TB) treatments by helping infected cells die a gentler death, investigators ...

The 25% reduction in the price of pretomanid could save Global Drug Facility clients upwards of $3 million a year.

This treatment is given when TB is either resistant to rifampicin, a critical first-line drug, or rifampicin and isoniazid, another first-line drug combination. These resistant strains are ...

A new study has identified a potential new therapy for pulmonary tuberculosis that could shorten the length of treatment and ...

M4TB, through its participation in ERA4TB – a European Union’s Horizon 2020 research and innovation program – is supporting initial development of a long-acting injectable ...

An experimental drug now in clinical trials as a cancer treatment could help boost the power of first-line tuberculosis (TB) treatments by helping infected cells die a gentler death, Johns Hopkins ...

Tuberculosis (TB) cases rose 13 per cent in England last year, with increases among both immigrants and people born in the UK ...

Study Finds Three New Safe, Effective Ways to Treat Drug-Resistant Tuberculosis Jan. 29, 2025 — Study finds three new safe and effective drug regimens to fight multidrug-resistant TB.

reduce the incidence of lung scarring or post-TB lung disease, and improve outcomes for patients with drug-resistant TB. Other Johns Hopkins researchers who contributed to this study include Mona ...

Many European countries are off track to meet official goals on HIV, TB, hepatitis, and STIs, a new report shows.View on ...